Journal of King Saud University: Science (Feb 2023)

Effects of comfort care combined with blue-light phototherapy on neonatal jaundice and total bilirubin and high-sensitivity C-reactive protein levels

  • Jie Jiao

Journal volume & issue
Vol. 35, no. 2
p. 102483

Abstract

Read online

In order to explore the effects of comfort care combined with blue-light phototherapy on neonatal jaundice and total bilirubin (TBIL) and high-sensitivity C-reactive protein (hsCRP) levels, this study selected 100 neonates as research objects. Those 100 neonates were diagnosed with neonatal jaundice in a designated hospital of this study from December 2020 to December 2021, and randomly divided into observation group and control group with 50 cases in each group. The neonates in control group were given blue-light phototherapy, while the neonates in observation group were given comfort care combined with blue-light phototherapy. Before and after the treatment, the neonates in the two groups were evaluated for their quiet sleep time, the number of crying, decrease in jaundice, weight gain, and TBIL and hs-CRP levels, and compared those indicators for follow-up analysis. The results of this study show that the total effective rate was 96.0 % (48/50) in the observation group and 82.0 % (41/50) in the control group, with statistically significant difference between the two groups (P 0.05); after treatment, the TBIL level [(99.27 ± 11.35) μmol/l] and hs-CRP level [(1.18 ± 0.32) μmol/l] of the observation group and the TBIL level [(123.25 ± 19.43) μmol/l] and hs-CRP level [(1.62 ± 0.45) μmol/l] of the control group were both lower than those before treatment, while the reduction degree of those in the observation group was better than that of the control group with statistically significant difference (P < 0.05). Therefore, the comfort care combined with blue-light phototherapy can achieve more ideal treatment effects than that of single use of blue-light phototherapy, which proves that the two treatment methods have certain synergy and provides a new potential technology for the prevention and treatment of neonatal jaundice.

Keywords